Secondary Hypertension: Renovascular Hypertension

Hypertension: A Companion to Braunwald's Heart Disease

Volumn , Issue , 2007, Pages 93-105

  Elliott, William J ^a  

^a RUSH MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34548440132     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-3053-9.50014-7     Document Type: Chapter

References (75)

1. Alcazar JM, Rodicio JL European Society of Hypertension: How to handle renovascular hypertension. J Hypertens 2001, 19:2109-2111.
2. 1995 Update of the Working Group Reports on Chronic Renal Failure and Renovascular Hypertension National High Blood Pressure Education Program Working Group. Arch Intern Med 1996, 156:1938-1947.
3. 2003 European Society of Hypertension European cardiology guidelines for the management of arterial hypertension: Guidelines Committee. J Hypertens 2003, 21:1011-1053.
4. National High Blood Pressure Education Program Coordinating Committee Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Hypertension 2003, 42:1206-1252.
5. Goldblatt H, Lynch J, Hanzal RF, Summerville WW Studies on experimental hypertension. I. The production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med 1934, 59:347-380.
6. Safian RD, Textor SC Renal-artery stenosis. N Engl J Med 2001, 344:431-442.
7. Maxwell MH, Bleifer KS, Franklin SS, Varady PD Cooperative study of renovascular hypertension: Demographic analysis of the results. JAMA 1972, 220:1195-1204.
8. Eyler WR, Clark MD, Garman JE, et al. Angiography of the renal areas including a comparative study of renal arterial stenoses in patients with and without hypertension. Radiology 1962, 78:879-892.
9. Buller CE, Nogareda JG, Ramanathan K, et al. The profile of cardiac patients with renal artery stenosis. J Am Coll Cardiol 2003, 43:1606-1613.
10. Weinrauch LA, D'Elia JA Renal artery stenosis: "Fortuitous diagnosis," problematic therapy [editorial]. J Am Coll Cardiol 2003, 43:1614-1616.
11. Smith HW Unilateral nephrectomy in hypertensive disease. J Urol 1956, 76:685-701.
12. Begelman SM, Olin JW Fibromuscular dysplasia. Curr Opinion Rheumatol 2000, 12:41-47.
13. Harrison EG, McCormack LJ Pathologic classification of renal arterial disease in renovascular hypertension. Mayo Clin Proc 1971, 46:161-167.
14. Kem DC, Lyons DF, Wenzl J, et al. Renin-dependent hypertension caused by nonfocal stenotic aberrant renal arteries: Proof of a new syndrome. Hypertension 2005, 46:380-385.
15. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002, 360:1903-1913. Prospective Studies Collaborative.
16. Caps MT, Perissinotto C, Zierler RE, et al. Prospective study of atherosclerotic disease progression of the renal artery. Circulation 1998, 98:2866-2872.
17. Caps MT, Zierler RE, Polissar NL, et al. Risk of atrophy in kidneys with atherosclerotic renal artery stenosis. Kidney Int 1998, 53:735-742.
18. Edwards MS, Craven TE, Burke GL, et al. Renovascular disease and the risk of adverse coronary events in the elderly: A prospective, population-based study. Arch Intern Med 2005, 165:207-213.
19. Textor SC, Wilcox CS Renal artery stenosis: A common, treatable cause of renal failure?. Annu Rev Med 2001, 52:421-442.
20. Fatica RA, Port FK, Young EW Incidence trends and mortality in end-stage renal disease attributed to renovascular disease in the United States. Am J Kidney Dis 2001, 37:1184-1190.
21. Barger AC The Goldblatt memorial lecture. Part I. Experimental renovascular hypertension. Hypertension 1979, 1:447-455.
22. Soulez G, Oliva VL, Turpin S, et al. Imaging of renovascular hypertension: Respective values of renal scintigraphy, renal Doppler US, and MR angiography. Radiographics 2000, 20:1355-1368.
23. Claus T, Schmitt R, Stabroth C, et al. Where do we stand with renovascular hypertension?. Nephrol Dial Transplant 2005, 20:1495-1498.
24. Shepherd S, Cadwallader K, Jankowski TA Does early detection of suspected atherosclerotic renovascular hypertension change outcomes?. J Family Pract 2005, 54:813-816.
25. Rosner MH Renovascular hypertension: Can we identify a population at high risk?. Southern Med J 2001, 94:1058-1064.
26. Krijnen P, van Jaarsveld BC, Steyerberg EW, et al. A clinical prediction rule for renal artery stenosis. Ann Intern Med 1998, 129:738-740.
27. Krijnen P, Steyerberg EW, Postma CT, et al. Validation of a prediction rule for renal artery stenosis. J Hypertens 2005, 23:1583-1588.
28. Vasbinder GB, Nelemans PJ, Kessels AG, et al. Diagnostic tests for renal artery stenosis in patients suspected of having renovascular hypertension: A meta-analysis. Ann Intern Med 2001, 135:401-411.
29. Vasbinder GBC, Nelemans PJ, Kessels AGH, et al. Accuracy of computed tomographic angiography and magnetic resonance angiography for diagnosing renal artery stenosis: Renal Artery Diagnostic Imaging Study in Hypertension (RADISH) Study Group. Ann Intern Med 2004, 141:674-682.
30. Muller FB, Sealey JE, Case DB, et al. The captopril test for identifying renovascular disease in hypertensive patients. Am J Med 1986, 80:633-644.
31. Postma CT, van der Steen PHM, Hoefnagels WHL, et al. The captopril test in the detection of renovascular disease in hypertensive patients. Arch Intern Med 1990, 150:625-628.
32. Elliott WJ, Martin WB, Murphy MB Comparison of two noninvasive screening tests for renovascular hypertension. Arch Intern Med 1993, 153:755-764.
33. Taylor AJ, Fletcher JW, Nally JV, et al. Procedure guideline for diagnosis of renovascular hypertension: Society of Nuclear Medicine. J Nucl Med 1998, 39:1297-1302.
34. van Jaarsveld BC, Krikjnen P, Derkx F, et al. The place of renal scintigraphy in the diagnosis of renal artery stenosis: Fifteen years of clinical experience. Arch Intern Med 1997, 157:1226-1234.
35. Fommei E, Ghione S, Hilson AJW, et al. Captopril radionuclide test in renovascular hypertension: A European multicentre study. Eur J Nucl Med 1993, 20:617-623.
36. Svetkey LP, R Wilkinson J, Dunnick NR, et al. Captopril renography in the diagnosis of renovascular disease. Am J Hypertens 1991, 4:711S-715S.
37. Taylor A Renovascular hypertension: Nuclear medicine techniques. Q J Nucl Med 2002, 46:268-282.
38. van Jaarsveld BC, Krijnen P, Pieterman H, et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis: Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med 2000, 342:1007-1014.
39. Blaufox MD, Middleton ML, Bongiovanni J, Davis BR Cost efficacy of the diagnosis and therapy of renovascular hypertension. J Nucl Med 1996, 37:171-177.
40. Lee H-Y, Grant EG Sonography in renovascular hypertension. J Ultrasound Med 2002, 21:431-441.
41. Radermacher J, Chavan J, Bleck J, et al. Use of Doppler ultrasound to predict the outcome of therapy for renal artery stenosis. N Engl J Med 2001, 344:410-417.
42. Soulez G, Therasse E, Qanadli SD, et al. Prediction of clinical response after renal angioplasty: Respective value of renal Doppler sonography and scintigraphy. AJR Am J Roentgenol 2003, 181:1029-1035.
43. Bolduc JP, Oliva VL, Therasse E, et al. Diagnosis and treatment of renovascular hypertension: A cost-benefit analysis. AJR Am J Roentgenol 2005, 184:931-937.
44. Binkert CA, Debatin JF, Schneider E, et al. Can MR measurement of renal artery flow and renal volume predict the outcome of percutaneous transluminal renal angioplasty?. Cardiovasc Intervent Radiol 2001, 24:233-239.
45. Qanadli SD, Soulez G, Therasse E, et al. Detection of renal artery stenosis: Prospective comparison of captopril-enhanced Doppler sonography, captopril-enhanced scintigraphy, and MR angiography. AJR Am J Roentgenol 2001, 177:1123-1129.
46. Carlos RC, Axelroad DA, Ellis JH, et al. Incorporating patient-centered outcomes in the analysis of cost-effectiveness: Imaging strategies for renovascular hypertension. AJR Am J Roentgenol 2003, 181:1653-1661.
47. Radermacher J, Haller H The right diagnostic work-up: Investigating renal and renovascular disorders. J Hypertens 2003, 21(Suppl2):S19-S24.
48. Gowda MS, Loeb AL, Crouse LJ, Kramer PH Complementary roles of color-flow duplex imaging and intravascular ultrasound in the diagnosis of renal artery fibromuscular dysplasia: Should renal arteriography serve as the "gold standard?". J Am Coll Cardiol 2003, 41:1305-1311.
49. Textor SC Managing renal arterial disease and hypertension. Curr Opin Cardiol 2003, 18:260-267.
50. Aqel RA, Zoghbi GJ, Baldwin SA, et al. Prevalence of renal artery stenosis in high-risk veterans referred to cardiac catheterization. J Hypertens 2003, 21:1157-1162.
51. Lederman RJ, Mendelsohn FO, Santos R, et al. Primary renal artery stenting: Characteristics and outcomes after 363 procedures. Am Heart J 2001, 142:314-323.
52. Haller C Arteriosclerotic renal artery stenosis: Conservative versus interventional management. Heart 2002, 88:193-197.
53. Chabova V, Schirger A, Stanson AW, et al. Outcomes of atherosclerotic renal artery stenosis managed without revascularization. Mayo Clin Proc 2000, 75:437-444.
54. Pillay WR, Kan YM, Crinnion JN, et al. Prospective multicentre study of the natural history of atherosclerotic renal artery stenosis in patients with peripheral vascular disease. Br J Surg 2002, 89:737-740.
55. Plouin PF Stable patients with atherosclerotic renal artery stenosis should be treated first with medical management. Am J Kidney Dis 2003, 42:851-857.
56. Fernando D, Garasic J Percutaneous intervention for renovascular disease: Rationale and patient selection. Curr Opin Cardiol 2004, 19:582-588.
57. Novick AC, Ziegelbaum M, Vidt DG, et al. Trends in surgical revascularization for renal artery disease: Ten years' experience. JAMA 1987, 257:498-501.
58. Aurell M, Jensen G Treatment of renovascular hypertension. Nephron 1997, 75:373-383.
59. Galaria II, Surowiec SM, Rhodes JM, et al. Percutaneous and open renal revascularizations have equivalent long-term functional outcomes. Ann Vasc Surg 2005, 19:218-228.
60. van de Ven PJ, Kaatee R, Beutler JJ, et al. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: A randomised trial. Lancet 1999, 353:282-286.
61. Mounier-Vehier C, Haulon S, Lions C, et al. Renal atrophy in atherosclerotic renovascular disease: Gradual changes 6 months after successful angioplasty. J Endovase Ther 2002, 9:863-872.
62. Durros G, Jaff M, Mathiak L, et al. Multicenter Palmaz stent renal artery stenosis revascularization registry report: Four-year follow-up of 1068 successful patients. Catheter Cardiovasc Interv 2002, 55:182-188.
63. Isles CG, Robertson S, Hill D Management of renovascular disease: A review of renal artery stenting in 10 studies. Q J Med 1999, 92:159-167.
64. Gill KS, Fowler RC Atherosclerotic renal arterial stenosis: Clinical outcomes of stent placement for hypertension and renal failure. Radiology 2003, 226:821-826.
65. Watson PS, Hadipetrou P, Cox SV, et al. Effect of renal artery stenting on renal function and size in patients with atherosclerotic renovascular disease. Circulation 2000, 102:1671-1677.
66. Beutler JJ, van Ampting JMA, van der Ven PJG, et al. Long-term effects of arterial stenting on kidney function for patients with ostial atherosclerotic renal artery stenosis and renal insufficiency. J Am Soc Nephrol 2001, 12:1475-1481.
67. Silva JA, Chan AW, White CJ, et al. Elevated brain natriuretic peptide predicts blood pressure response after stent revascularization in patients with renal artery stenosis. Circulation 2005, 111:328-333.
68. Hollenberg NK Medical therapy for renovascular hypertension: A review. Am J Hypertens 1988, 1:338S-343S.
69. Weibull H, Bergqvist D, Bergentz SE, et al. Percutaneous transluminal renal angioplasty versus surgical reconstruction of atherosclerotic renal artery stenosis: A prospective randomized study. J Vasc Surg 1993, 18:841-852.
70. Uzzo RG, Novick AC, Goormastic M, et al. Medical vs. surgical management of atherosclerotic renal artery stenosis. Transplant Proc 2002, 34:723-725.
71. Plouin PF, Chatellier G, Darne B, Raynaud A Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: A randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension 1998, 31:823-829.
72. Webster J, Marshall F, Abdalla M, et al. Randomised comparison of percutaneous angioplasty vs. continued medical therapy for hypertensive patients with atheromatous renal artery stenosis: Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J Hum Hypertens 1998, 12:329-335.
73. Bax L, Mali WP, Buskens E, et al. The benefit of STent placement and blood pressure and lipid-lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery: The STAR study. Rationale and study design. J Nephrol 2003, 16:807-817.
74. Ives NJ, Wheatley K, Stowe RL, et al. Continuing uncertainty about the value of percutaneous revascularization in atherosclerotic renovascular disease: A meta-analysis of randomized trials. Nephrol Dial Transplant 2003, 18:298-304.
75. Nordmann AJ, Wood K, Parkes R, Logan AG Balloon angioplasty or medical therapy for hypertensive patients with atherosclerotic renal artery stenosis? A meta-analysis of randomized controlled trials. Am J Med 2003, 114:44-50.